Status:
UNKNOWN
Hysterectomy Versus Uterine Preservation for Pelvic Organ Prolapse Surgery
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
The MSI Foundation
Conditions:
Pelvic Organ Prolapse
Eligibility:
FEMALE
18-99 years
Brief Summary
Pelvic organ prolapse (POP) is the descent of pelvic organs into the vagina resulting in bulge symptoms and occurs in approximately 50% of women. Almost 20% of women will elect surgical correction of ...
Eligibility Criteria
Inclusion
- Have diagnosed POP of stage ≥2 using the globally recognized Pelvic Organ Prolapse-Quantification System (POP-Q)
- Elect surgical management of POP
- Demonstrate presence of apical prolapse on clinical exam deemed to require either a hysterectomy and concomitant vaginal vault suspension or uterine suspension to properly address their POP during surgical correction
- Desire no further pregnancy
- Can communicate in English
- Are ≥18 years in age
Exclusion
- Prior hysterectomy
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
321 Patients enrolled
Trial Details
Trial ID
NCT04890951
Start Date
July 1 2020
End Date
December 1 2024
Last Update
June 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pelvic Floor Clinic
Calgary, Alberta, Canada